Pharmacogenomics. 2002 Sep;3(5):679-86.

The hunt for new genes and polymorphisms that can control the response to drugs.

Source

Genetic Health Services Victoria, Murdoch Childrens Research Institute, University of Melbourne, Melbourne, Australia. sheffld@cryptic.rch.unimelb.edu.au

Abstract

There has been a great increase in the knowledge of understanding the genetic basis for individual variation in response to drugs. The study of variation in gene structure (polymorphism) can now predict the likely metabolic behavior in an individual for a number of drugs. This review documents the different strategies that can be used to find new genes and polymorphisms within these genes. Candidate genes can be used in case-control studies or studies where the parents of the person having an adverse effect from the drug are used as controls. New genes are being discovered in the drug development process and the technological development in molecular biology is expected to greatly enhance knowledge of the genes that regulate drug metabolism.

PMID:: 12223052; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Supplemental Content

Save items

Related citations in PubMed

Review Pharmacogenetics in drug discovery and development: a translational perspective. [Nat Rev Drug Discov. 2008]
Review Pharmacogenetics in drug discovery and development: a translational perspective.
Roses AD. Nat Rev Drug Discov. 2008 Oct; 7(10):807-17. Epub 2008 Sep 19.
Review How and why to screen for CYP2D6 interindividual variability in patients under pharmacological treatments. [Curr Drug Metab. 2010]
Review How and why to screen for CYP2D6 interindividual variability in patients under pharmacological treatments.
De Gregori M, Allegri M, De Gregori S, Garbin G, Tinelli C, Regazzi M, Govoni S, Ranzani GN. Curr Drug Metab. 2010 Mar; 11(3):276-82.
Review Pharmacogenetics. [Br Med Bull. 1999]
Review Pharmacogenetics.
Wolf CR, Smith G. Br Med Bull. 1999; 55(2):366-86.
Review Pharmacogenetic aspects of drug-induced torsade de pointes: potential tool for improving clinical drug development and prescribing. [Drug Saf. 2004]
Review Pharmacogenetic aspects of drug-induced torsade de pointes: potential tool for improving clinical drug development and prescribing.
Shah RR. Drug Saf. 2004; 27(3):145-72.
Review Effect of pharmacogenetics on medicine. [Environ Mol Mutagen. 2001]
Review Effect of pharmacogenetics on medicine.
Weber WW. Environ Mol Mutagen. 2001; 37(3):179-84.

See reviews... See all...

Cited by 1 PubMed Central article

Clinical use of pharmacogenomic tests in 2009. [Clin Biochem Rev. 2009]
Clinical use of pharmacogenomic tests in 2009.
Sheffield LJ, Phillimore HE. Clin Biochem Rev. 2009 May; 30(2):55-65.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

The hunt for new genes and polymorphisms that can control the response to drugs.
The hunt for new genes and polymorphisms that can control the response to drugs.
Pharmacogenomics. 2002 Sep ;3(5):679-86.

PubMed
Non-classical 21-hydroxylase deficiency in children: association of adrenocortic...
Non-classical 21-hydroxylase deficiency in children: association of adrenocorticotropic hormone-stimulated 17-hydroxyprogesterone with the risk of compound heterozygosity with severe mutations.
Acta Paediatr. 2002 ;91(8):892-8.

PubMed
Clinical trials with hypericum extracts in patients with depression--results, co...
Clinical trials with hypericum extracts in patients with depression--results, comparisons, conclusions for therapy with antidepressant drugs.
Phytomedicine. 2002 Jul ;9(5):468-74.

PubMed
Dose conversion from recombinant human erythropoietin to darbepoetin alfa: recom...
Dose conversion from recombinant human erythropoietin to darbepoetin alfa: recommendations from clinical studies.
Pharmacotherapy. 2002 Sep ;22(9 Pt 2):160S-165S.

PubMed
Prevalence and causes of blindness and low vision in Dambatta local government a...
Prevalence and causes of blindness and low vision in Dambatta local government area, Kano State, Nigeria.
Niger J Med. 2002 Jul-Sep ;11(3):108-12.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: